Skip to content
← Full study record

NCT00094497 · BASELINE

Baseline characteristics

Trial in Locally Advanced and Metastatic Adrenocortical Carcinoma Treatment (FIRM-ACT) · Source last updated 2016-09-21

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

denoms
  1. counts
    1. group Id
      BG000
      value
      151
    2. group Id
      BG001
      value
      153
    3. group Id
      BG002
      value
      304
    units
    Participants
groups
  1. description
    etopodide, doxorubicin, cisplatin and mitotane Etoposide Doxorubicin Cisplatin Mitotane participants who progressed during first line therapy, were eligible to the alternative treatment (Sz-M)
    id
    BG000
    title
    EDP-M
  2. description
    streptozotocin and mitotane Streptozotocin Mitotane participants who progressed during first line therapy, were eligible to the alternative treatment (EDP-M)
    id
    BG001
    title
    Sz-M
  3. description
    Total of all reporting groups
    id
    BG002
    title
    Total
measures
  1. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          value
          151
        2. group Id
          BG001
          value
          153
        3. group Id
          BG002
          value
          304
      title
      >= 18 years
    param Type
    NUMBER
    title
    Age, Customized
    unit Of Measure
    participants
  2. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          value
          91
        2. group Id
          BG001
          value
          92
        3. group Id
          BG002
          value
          183
        title
        Female
      2. measurements
        1. group Id
          BG000
          value
          60
        2. group Id
          BG001
          value
          61
        3. group Id
          BG002
          value
          121
        title
        Male
    param Type
    COUNT_OF_PARTICIPANTS
    title
    Sex: Female, Male
    unit Of Measure
    Participants
  3. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          value
          0
        2. group Id
          BG001
          value
          1
        3. group Id
          BG002
          value
          1
      title
      III
    2. categories
      1. measurements
        1. group Id
          BG000
          value
          151
        2. group Id
          BG001
          value
          152
        3. group Id
          BG002
          value
          303
      title
      IV
    param Type
    NUMBER
    title
    tumor stage
    unit Of Measure
    participants
  4. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          value
          73
        2. group Id
          BG001
          value
          72
        3. group Id
          BG002
          value
          145
      title
      0
    2. categories
      1. measurements
        1. group Id
          BG000
          value
          64
        2. group Id
          BG001
          value
          60
        3. group Id
          BG002
          value
          124
      title
      1
    3. categories
      1. measurements
        1. group Id
          BG000
          value
          13
        2. group Id
          BG001
          value
          21
        3. group Id
          BG002
          value
          34
      title
      2
    4. categories
      1. measurements
        1. group Id
          BG000
          value
          1
        2. group Id
          BG001
          value
          0
        3. group Id
          BG002
          value
          1
      title
      4
    description
    Eastern Cooperative Oncology Group performance status score (ranges from 0, asymptomatic - 5, dead)
    param Type
    NUMBER
    title
    ECOG
    unit Of Measure
    participants
Complete source fields
denoms
  1. counts
    1. group Id
      BG000
      value
      151
    2. group Id
      BG001
      value
      153
    3. group Id
      BG002
      value
      304
    units
    Participants
groups
  1. description
    etopodide, doxorubicin, cisplatin and mitotane Etoposide Doxorubicin Cisplatin Mitotane participants who progressed during first line therapy, were eligible to the alternative treatment (Sz-M)
    id
    BG000
    title
    EDP-M
  2. description
    streptozotocin and mitotane Streptozotocin Mitotane participants who progressed during first line therapy, were eligible to the alternative treatment (EDP-M)
    id
    BG001
    title
    Sz-M
  3. description
    Total of all reporting groups
    id
    BG002
    title
    Total
measures
  1. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          value
          151
        2. group Id
          BG001
          value
          153
        3. group Id
          BG002
          value
          304
      title
      >= 18 years
    param Type
    NUMBER
    title
    Age, Customized
    unit Of Measure
    participants
  2. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          value
          91
        2. group Id
          BG001
          value
          92
        3. group Id
          BG002
          value
          183
        title
        Female
      2. measurements
        1. group Id
          BG000
          value
          60
        2. group Id
          BG001
          value
          61
        3. group Id
          BG002
          value
          121
        title
        Male
    param Type
    COUNT_OF_PARTICIPANTS
    title
    Sex: Female, Male
    unit Of Measure
    Participants
  3. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          value
          0
        2. group Id
          BG001
          value
          1
        3. group Id
          BG002
          value
          1
      title
      III
    2. categories
      1. measurements
        1. group Id
          BG000
          value
          151
        2. group Id
          BG001
          value
          152
        3. group Id
          BG002
          value
          303
      title
      IV
    param Type
    NUMBER
    title
    tumor stage
    unit Of Measure
    participants
  4. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          value
          73
        2. group Id
          BG001
          value
          72
        3. group Id
          BG002
          value
          145
      title
      0
    2. categories
      1. measurements
        1. group Id
          BG000
          value
          64
        2. group Id
          BG001
          value
          60
        3. group Id
          BG002
          value
          124
      title
      1
    3. categories
      1. measurements
        1. group Id
          BG000
          value
          13
        2. group Id
          BG001
          value
          21
        3. group Id
          BG002
          value
          34
      title
      2
    4. categories
      1. measurements
        1. group Id
          BG000
          value
          1
        2. group Id
          BG001
          value
          0
        3. group Id
          BG002
          value
          1
      title
      4
    description
    Eastern Cooperative Oncology Group performance status score (ranges from 0, asymptomatic - 5, dead)
    param Type
    NUMBER
    title
    ECOG
    unit Of Measure
    participants

Download exact source JSON → · Snapshot ctgov-results-191f4516d4760045304b24a0

Preserved source evidence · Not medical advice